Peptide Receptor Radionuclide Therapy with

Animals Biological Transport Cell Line, Tumor Cell Transformation, Neoplastic Copper Radioisotopes / therapeutic use Disease Models, Animal Female Mice Mice, Inbred BALB C Neuroendocrine Tumors / diagnostic imaging Octreotide / analogs & derivatives Positron Emission Tomography Computed Tomography Receptors, Somatostatin / metabolism Somatostatin / metabolism
64Cu 67Cu peptide receptor radionuclide therapy radiopharmaceuticals theranostics

Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
12 2020
Historique:
received: 13 02 2020
accepted: 16 04 2020
pubmed: 18 5 2020
medline: 6 3 2021
entrez: 17 5 2020
Statut: ppublish

Résumé

Peptide receptor radionuclide therapy (PRRT) using radiolabeled octreotate is an effective treatment for somatostatin receptor 2-expressing neuroendocrine tumors. The diagnostic and therapeutic potential of

Identifiants

DOI: 10.2967/jnumed.120.243543 PMID: 32414949
pubmed: 32414949
pii: jnumed.120.243543
doi: 10.2967/jnumed.120.243543
doi:

Substances chimiques

64Cu-SARTATE 0
Copper Radioisotopes 0
Copper-67 0
Receptors, Somatostatin 0
Somatostatin 51110-01-1
Octreotide RWM8CCW8GP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1800-1805

Informations de copyright

© 2020 by the Society of Nuclear Medicine and Molecular Imaging.

Auteurs

Carleen Cullinane (C)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Charmaine M Jeffery (CM)

Clarity Pharmaceuticals Ltd., Eveleigh, New South Wales, Australia.

Peter D Roselt (PD)

Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Ellen M van Dam (EM)

Clarity Pharmaceuticals Ltd., Eveleigh, New South Wales, Australia.

Susan Jackson (S)

Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Kevin Kuan (K)

Molecular Imaging and Therapy Research Unit, SAHMRI, Adelaide, South Australia, Australia; and.

Price Jackson (P)

Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

David Binns (D)

Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Jessica van Zuylekom (J)

Research Division, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Matthew J Harris (MJ)

Clarity Pharmaceuticals Ltd., Eveleigh, New South Wales, Australia.

Rodney J Hicks (RJ)

Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Centre for Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Paul S Donnelly (PS)

School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Victoria, Australia pauld@unimelb.edu.au rod.hicks@petermac.org.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Meal Timing and Anthropometric and Metabolic Outcomes: A Systematic Review and Meta-Analysis.

Hiu Yee Liu, Ashley A Eso, Nathan Cook et al.
1.00
Humans Meals Time Factors Female Adult

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Métabolisme › Transport biologique › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Carcinogenèse › Transformation cellulaire néoplasique › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Produits chimiques inorganiques › Isotopes › Radio-isotopes › Radio-isotopes du cuivre › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Techniques d'investigation › Modèles théoriques › Modèles biologiques › Modèles animaux de maladie humaine › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée BALB C › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Octréotide › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Tomoscintigraphie › Tomographie par émission de positons › Tomographie par émission de positons couplée à la tomodensitométrie › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs peptidiques › Récepteur hormones hypothalamiques hypophysotropes régulatrices › Récepteur somatostatine › Peptide Receptor Radionuclide Therapy with
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines de tissu nerveux › Neuropeptides › Hormones hypothalamiques › Hormones hypothalamiques hypophysotropes inhibitrices › Somatostatine › Peptide Receptor Radionuclide Therapy with